Mika K. Derynck SEC EDGAR Filings (CIK 0001865125)

SEC EDGAR filings, ownership reports, and insider transactions for Mika K. Derynck.

Business address
C/O Amunix Pharmaceuticals, Inc., 2 Tower Place, #1100, South San Francisco, CA, 94080
Get insider transactions for this reporting owner
Mika K. Derynck has filed 7 SEC EDGAR filings since 27 Feb 2023

Latest Filings

Recent SEC filings for Mika K. Derynck including 4, 4/A, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 17 Feb 2026 12 Feb 2026 001-39247
4 Open 4 document View SEC filing for 4 10 Feb 2025 06 Feb 2025 001-39247
4/A Open 4/A document View SEC filing for 4/A 20 Feb 2024 13 Feb 2024 001-39247
4 Open 4 document View SEC filing for 4 15 Feb 2024 13 Feb 2024 001-39247
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Apr 2023 23 Feb 2023 001-39247
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Feb 2023 23 Feb 2023 001-39247
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 27 Feb 2023 23 Feb 2023 001-39247

About this filer

Mika K. Derynck files with the SEC under CIK 0001865125. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages